Alydia Health this week said it has appointed Paul Praino as its VP of sales.
Praino will be responsible for expanding the company’s sales efforts for the Jada System, Alydia Health’s device that is designed to encourage normal contraction of the uterus to rapidly stop excessive bleeding after childbirth.
“Paul is an experienced commercial sales leader who is skilled at hiring, developing and motivating his team to meet the scalability needs of high-growth organizations and deliver sales results,” CEO Rob Binney said in a news release. “As we prepare to join Organon and build a high-performing medical device sales organization, we believe Paul is the right person to lead the acceleration of the Jada System launch to more hospitals and patients across the U.S.”
Priano has more than 15 years of experience in medical device sales. He most recently served as global VP of sales at Intersect ENT. He has also held numerous leadership roles at Access Closure and Acclarent.
Alydia Health recently entered into a definitive agreement in which Merck spinoff Organon will acquire Alydia Health.